Awaiting Regulatory Approvals For Insulin Trials: Kiran Mazumdar Shaw
  • Saba Ashraf
  • Jul 26 2013

July 26: Kiran Mazumdar Shaw, Chairman and MD at Biocon, talks about the progress made in the oral insulin trials. “We need to make sure there are no regulatory approval delays,” she says, adding that any such delay pushes the company behind its deadline.